Ahmed M Awad DO

Assistant Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine

4320 Wornall RdSte 208Kansas City, MO 64111
Phone+1 816-531-0552
Fax+1 816-756-2503

Dr. Awad is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Awad's full profile Already have an account?

Education & Training

University of Missouri-Kansas City School of MedicineFellowship, Nephrology, 1997 - 1999
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1994 - 1997
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State License 1996 - 2027
KS State License 1997 - 2026
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Greenway Prime Suite, Greenway Health, LLC, 2014-2017
CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2014-2017
CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2014-2017

Clinical Trials

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria Start of enrollment: 2023 Dec 14
COMPLETED
PHASE2
Roles: Contact
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension Start of enrollment: 2023 Nov 22
COMPLETED
PHASE3
Roles: Contact

Publications & Presentations

PubMed

20 citations
A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
Gil Yosipovitch, Ahmed Awad, Robert H Spencer, Catherine Munera, Frédérique Menzaghi
Journal of the American Academy of Dermatology. 2023-08-01
117 citations
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
Kai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, Ahmed Awad, Geoffrey A. Block
The New England Journal of Medicine. 2021-04-28
3 citations
A practical synthesis of xylo- and arabinofuranoside precursors by diastereoselective reduction using Corey-Bakshi-Shibata catalyst.
Lynn Marie Utley, Jessica Maldonado, Ahmed M. Awad
Nucleosides, Nucleotides & Nucleic Acids. 2018-01-16